
A South Korean Biotech Firms Gets $183.3M Funding to Build Bitcoin Treasury
Bridge Biotherapeutics (288330), a South Korean biotech company, may be looking to become the country’s answer to Strategy (MSTR) or Metaplanet (3350) by adopting a bitcoin treasury strategy. Seongnam-based Bridge has received a 25 billion won ($183.3 million) backing from crypto investment firm Parataxis, with which it will build a BTC treasury. Bridge will change…